Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation
Language English Country United States Media print-electronic
Document type Clinical Trial, Letter, Research Support, Non-U.S. Gov't
Grant support
PROGRES Q28/LF1
Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations - International
PROGRES Q26/LF1
Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations - International
UNCE/MED/016
Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations - International
AZV 17-28980A
Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations - International
Charles University Center of Excellence - International
Ministry of Health of the Czech Republic - International
PubMed
30474171
DOI
10.1002/ajh.25362
Knihovny.cz E-resources
- MeSH
- Survival Analysis MeSH
- Transplantation, Autologous MeSH
- Progression-Free Survival MeSH
- Adult MeSH
- Remission Induction methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Lymphoma, Mantle-Cell mortality therapy MeSH
- Antineoplastic Combined Chemotherapy Protocols therapeutic use MeSH
- Rituximab therapeutic use MeSH
- Aged MeSH
- Hematopoietic Stem Cell Transplantation MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Letter MeSH
- Clinical Trial MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Rituximab MeSH
1st Medical Department Charles University General Hospital Prague Czech Republic
Department of Hematology and Oncology Masaryk University Hospital Brno Czech Republic
Department of Pathology Charles University Medical Faculty Plzen Prague Czech Republic
Institute of Pathology Charles University General Hospital Prague Czech Republic
References provided by Crossref.org
Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma